Medication info
Hysartan Tablets 8mg (Candesartan Cilexetil)

Hysartan Tablets 8mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
Light yellow-pink, round, biconvex tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201403335 · Approved 2014.07.23 · Insurance code 656003650

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to manage essential hypertension, that is, high blood pressure. It is also effective in patients with heart failure whose heart function is impaired, particularly when there is left ventricular systolic dysfunction or reduced left ventricular ejection fraction. It is particularly suitable for patients who need to use an ACE inhibitor additionally or have poor tolerance to ACE inhibitors. Therefore, it helps stabilize blood pressure and improve symptoms of heart failure.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Children: The safety and efficacy of this medicine have not been established in adolescents and children aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used by pregnant or potentially pregnant women, breastfeeding women, patients with severe liver dysfunction or cholestasis, patients with hereditary angioedema, and those with certain genetic lactose intolerance. Elderly patients, patients with hyperkalemia, patients with mild to moderate liver dysfunction, patients with heart valve disease, and those with poor kidney function should use this medication with caution. Side effects such as dizziness, back pain, and respiratory infections may occur during treatment, and patients with heart failure are at risk of hypotension, hyperkalemia, and worsening kidney function, so regular blood tests should be conducted to monitor their condition. Caution should be exercised when taking potassium supplements or medications rich in potassium, as potassium levels in the blood may increase. Additionally, since this medication lowers blood pressure, caution is needed when driving or operating machinery due to the potential for dizziness or drowsiness. When used in combination with other antihypertensive medicines or diuretics, interactions may cause blood pressure to drop too low or affect kidney function, so it should be taken as directed by a physician. The safety and efficacy of this drug have not been established in children and adolescents, so it is advisable not to use it in individuals under 18 years of age. In the event of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate contact with a healthcare professional is necessary for appropriate treatment. Finally, it should be kept out of the reach of children, and the medication should not be transferred to other containers for safety.

Side effects

Dizziness, low back pain, respiratory infection, upper respiratory infection, pharyngitis, rhinitis, asthenia, fever, altered sensation, dyspepsia, gastritis, tachycardia, palpitations, increase in creatine kinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, myalgia, epistaxis, anxiety, depression, somnolence, dyspnea, rash, increased sweating, hematuria, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, blood and lymphatic system abnormalities (leukopenia, neutropenia, agranulocytosis), hyponatremia, hypoglycemia, dizziness, headache, intestinal vascular edema, nausea, diarrhea, increased liver enzyme levels, hepatitis, elevated AST, elevated ALT, elevated γ-GTP, jaundice, urticaria, pruritus, angioedema, rhabdomyolysis, arthralgia, acute renal failure, interstitial pneumonia, shock, syncope, loss of consciousness, paralysis, muscle tension, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbance, decreased libido, memory loss, decreased appetite, increased appetite, tinnitus, altered taste, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is important to keep it at room temperature between 1 and 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Light yellow-pink, round, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.